EUVIMEDEUVIMED entdecken
Open Access

Timing and Method of Patient-Provider Communication for Abnormal Hepatocellular Carcinoma Screening Results in Cirrhosis

Jeremy Louissaint iD, Beverly Kyalwazi, John Deng, Timothy P Hogan iD, Robert W Turer iD, Elliot B Tapper, David E Gerber iD, Bryan D Steitz, Sarah R Lieber iD, Amit G Singal iD

JCO Clinical Cancer Informatics · 2025

DOI: 10.1200/cci-24-00269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2025. Verfasst von Jeremy Louissaint und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, TX. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Cirrhosis, Early Detection of Cancer. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Patients with cirrhosis undergo frequent abdominal imaging including semiannual hepatocellular carcinoma (HCC) screening, with results released immediately via the patient portal. We characterized time from patient review to patient-provider communication (PPC) for patients with abnormal liver imaging results. METHODS We identified patients with cirrhosis enrolled in the patient portal with a new abnormal liver lesion (LI-RADS, LR) on ambulatory liver ultrasound (US) or multiphasic computed tomography/magnetic resonance imaging. Imaging findings were grouped into low-risk (US-2, LR-2), intermediate-risk (US-3, LR-3), and high-risk (LR-4, LR-5, LR-M, LR-TIV) results. We extracted three date-time events from the electronic health record, including result release to the patient, patient review of the result, and result-related PPC. We compared communication methods and the median time with PPC after patient review of results between groups. RESULTS The cohort included 133 patients (median age, 62 years, 56% male) with 34 (25.6%) low-risk, 61 (45.9%) intermediate-risk, and 38 (28.6%) high-risk results. PPC for high-risk results was predominantly via telephone calls (60.5%), whereas portal messages were most commonly used for low- and intermediate-risk results (61.8% and 45.9%, respectively; P < .001). For patients who reviewed their result on the portal, most (79.3%) reviewed the result before PPC, among whom the median time between review and PPC was 55.8 (IQR, 22.0-219.0), 167 (IQR, 42.7-324.0), and 47.3 (IQR, 25.8-78.8) hours for low-, intermediate-, and high-risk results, respectively ( P = .02). CONCLUSION Portal-based review of abnormal imaging results by patients before provider communication is common, including results concerning a new HCC diagnosis. Further studies are needed to evaluate patient-reported outcomes, such as psychological distress, associated with this method of disclosing cancer-related results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLiver CirrhosisEarly Detection of CancerCommunicationPhysician-Patient RelationsHumansMaleFemaleMiddle AgedAgedMagnetic Resonance ImagingTomography, X-Ray ComputedUltrasonographyTime Factors

Autor:innen und Institutionen

  • Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, TX.
  • Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.
  • O'Donnell School of Public Health, UT Southwestern Medical Center, Dallas, TX.
  • Center for Health Optimization and Implementation Research (CHOIR), VA Bedford Healthcare System, Bedford, MA.
  • Department of Emergency Medicine, UT Southwestern Medical Center, Dallas, TX.
  • Clinical Informatics Center, UT Southwestern Medical Center, Dallas, TX.

ORCID-Profile: Jeremy Louissaint, Timothy P Hogan, Robert W Turer, David E Gerber, Sarah R Lieber, Amit G Singal

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS

Zitieren

APA

Louissaint, J., Kyalwazi, B., Deng, J., Hogan, T. P., Turer, R. W., Tapper, E. B., Gerber, D. E., Steitz, B. D., Lieber, S. R., & Singal, A. G. (2025). Timing and Method of Patient-Provider Communication for Abnormal Hepatocellular Carcinoma Screening Results in Cirrhosis. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci-24-00269

Vancouver

Louissaint J, Kyalwazi B, Deng J, Hogan TP, Turer RW, Tapper EB, et al. Timing and Method of Patient-Provider Communication for Abnormal Hepatocellular Carcinoma Screening Results in Cirrhosis. JCO Clinical Cancer Informatics. 2025. doi:10.1200/cci-24-00269

BibTeX
@article{Louissaint2025,
  author = {Louissaint, Jeremy and Kyalwazi, Beverly and Deng, John and Hogan, Timothy P and Turer, Robert W and Tapper, Elliot B and Gerber, David E and Steitz, Bryan D and Lieber, Sarah R and Singal, Amit G},
  title = {Timing and Method of Patient-Provider Communication for Abnormal Hepatocellular Carcinoma Screening Results in Cirrhosis},
  journal = {JCO Clinical Cancer Informatics},
  year = {2025},
  doi = {10.1200/cci-24-00269}
}
Kostenlos starten →